Glenn Dranoff Selected Research

Complementary DNA (cDNA)

3/2015	Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions.
3/2014	High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.
2/2009	Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
6/2008	Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
3/2003	Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.
3/2003	MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients.
10/2002	CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
5/2002	ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glenn Dranoff Research Topics

Disease

105	Neoplasms (Cancer) 01/2023 - 02/2002
25	Melanoma (Melanoma, Malignant) 03/2018 - 05/2002
10	Lung Neoplasms (Lung Cancer) 01/2017 - 03/2003
8	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2002
7	Leukemia 12/2022 - 10/2002
7	Inflammation (Inflammations) 01/2022 - 05/2003
6	Glioma (Gliomas) 04/2018 - 03/2006
5	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 03/2003
5	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 02/2002
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 02/2009
5	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 01/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 05/2002
5	Ovarian Neoplasms (Ovarian Cancer) 02/2014 - 03/2003
4	Disease Progression 07/2022 - 11/2008
4	Infections 10/2017 - 10/2006
4	Colorectal Neoplasms (Colorectal Cancer) 12/2016 - 12/2010
4	Necrosis 08/2011 - 04/2003
3	Breast Neoplasms (Breast Cancer) 07/2022 - 03/2009
3	Multiple Myeloma 01/2019 - 01/2004
3	Adenocarcinoma of Lung 01/2019 - 08/2015
3	Carcinoma (Carcinomatosis) 12/2016 - 04/2003
3	Experimental Melanoma 03/2014 - 02/2002
2	Injection Site Reaction 12/2022 - 11/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2006
2	Hypersensitivity (Allergy) 07/2017 - 01/2016
2	Cytokine Release Syndrome 12/2016 - 04/2015
2	Glioblastoma (Glioblastoma Multiforme) 02/2016 - 11/2014
2	Myeloid Leukemia (Leukemia, Myelocytic) 03/2015 - 03/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2012 - 02/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2002 - 05/2002
1	Neuroinflammatory Diseases 12/2022
1	Colitis 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020

Drug/Important Bio-Agent (IBA)

37	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 02/2002
34	VaccinesIBA 12/2022 - 05/2002
25	AntibodiesIBA 12/2022 - 05/2002
23	AntigensIBA 12/2022 - 02/2002
23	CytokinesIBA 01/2021 - 05/2003
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2003
9	LigandsIBA 01/2020 - 06/2006
8	Neoplasm Antigens (Tumor Antigens)IBA 04/2015 - 10/2002
8	Complementary DNA (cDNA)IBA 03/2015 - 05/2002
7	Cancer VaccinesIBA 12/2022 - 02/2002
5	Monoclonal AntibodiesIBA 12/2022 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 04/2018 - 12/2010
5	CTLA-4 AntigenIBA 06/2012 - 04/2003
4	micaIBA 01/2022 - 06/2006
4	InterferonsIBA 12/2020 - 05/2003
4	Interleukin-3 (Interleukin 3)IBA 01/2019 - 10/2006
4	Immune Checkpoint InhibitorsIBA 02/2016 - 08/2011
4	Staphylococcal Protein A (Protein A)IBA 02/2009 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2014
3	Inhibitor of Apoptosis ProteinsIBA 01/2018 - 03/2003
3	IpilimumabIBA 01/2017 - 08/2011
3	Peptides (Polypeptides)IBA 01/2017 - 03/2003
3	AutoantibodiesIBA 03/2014 - 10/2002
3	milk fat globuleIBA 06/2009 - 04/2008
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 11/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 02/2008
2	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2020 - 03/2018
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2019 - 06/2006
2	Interleukin-5 (Interleukin 5)IBA 01/2019 - 06/2009
2	Interleukin-2 (IL2)IBA 01/2018 - 04/2015
2	Interferon-gamma (Interferon, gamma)IBA 10/2017 - 05/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 06/2011
2	Polycomb Repressive Complex 2IBA 01/2017 - 01/2017
2	B7-H1 AntigenIBA 01/2017 - 02/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 12/2010
2	sipuleucel-T (APC8015)FDA Link 01/2016 - 08/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 03/2008
2	SuspensionsIBA 07/2015 - 02/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 09/2010
2	PolymersIBA 03/2014 - 02/2009
2	EnzymesIBA 06/2012 - 03/2003
2	Integrin beta3 (GPIIIa)IBA 06/2009 - 11/2008
2	AutoantigensIBA 06/2008 - 10/2002
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	canakinumab FDA Link 01/2023
1	gevokizumabIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 12/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 12/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	sabatolimabIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Chemotactic FactorsIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Protein Isoforms (Isoforms)IBA 03/2019

Therapy/Procedure

37	Immunotherapy 01/2023 - 10/2002
32	Therapeutics 12/2020 - 05/2003
4	Hematopoietic Stem Cell Transplantation 03/2015 - 10/2002
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2011 - 02/2002
2	Radiotherapy 01/2016 - 06/2009
2	Ligation 03/2014 - 06/2012
2	Drug Therapy (Chemotherapy) 03/2012 - 06/2009
1	Heterologous Transplantation (Xenotransplantation) 01/2021